Amedisys Inc (ADY.BE)
| Previous Close | 74.00 |
| Open | 74.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 74.00 - 74.00 |
| 52 Week Range | 67.00 - 74.00 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
4 Stocks to Hold in a Challenging Outpatient Home Health Industry
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, CHE, AMED and ADUS are well poised to gain.
- Investing.com
4 big deal reports: TriNet stock soars on word of potential sale
Here is your Pro Recap of 4 head-turning deal dispatches you may have missed this week: TriNet considers a sale, merger deals at Network International/Brookfield, Circor/KKR, and Optum’s unsolicited offer to Amedisys. Trinet (NYSE:TNET) shares jumped more than 9% on Friday after Reuters reported that the online payroll services provider is considering selling the company, citing sources familiar with the matter. According to the report, the company is in discussions with potential buyers, in collaboration with investment bank Morgan Stanley.
- Zacks
UnitedHealth (UNH) Intends to Buy Amedisys to Boost Home-Health
UnitedHealth (UNH) offers to combine its Optum business with Amedisys to expand its reach in the healthcare-at-home market.
